Skip to Main Content

Paper Details

Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression.
Leukemia
0
2024
Author NameAffiliation
Courtney D DiNardoM.D. Anderson Cancer Center, The University of Texas
Gautam BorthakurM.D. Anderson Cancer Center, The University of Texas
Hagop KantarjianM.D. Anderson Cancer Center, The University of Texas
  • 1 - 3

Datasets

Release 1.2